Page 27 - Arix Bioscience News Today

IN BRIEF: Arix responds to Acacias letter on executive changes Wed, 10th Mar 2021 19:23 Arix Bioscience PLC - focused on investing in biotech companies - Notes letter from 19% shareholder Acacia Research Corp calling for shake up of executive team due to "history of governance instability". Company expresses disappointment that Acacia published the letter on the same day it was received by Arix. "Arix has an experienced board that is committed to acting in the best interest of all shareholders....

Arix Bioscience PLC: Annual Results for the Twelve Months ended 31 December 2020 DJ Annual Results for the Twelve Months ended 31 December 2020 Arix Bioscience PLC (ARIX) Annual Results for the Twelve Months ended 31 December 2020 09-March-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. =-------------------------------------------------------------------------------------------...

  Acacia Research Corporation, a 19.05% shareholder in Arix Bioscience plc (LSE: ARIX), sent a letter to the Arix Senior Independent Director on 9 March 2021.   Acacia is urging the Arix Board to meet with its largest shareholder ahead of the start date of the recently appointed directors, currently scheduled for April 1, in order to allow for proper discourse on the multitude of shareholder concerns. Arix has a disappointing governance history with 18 different directors in just five years, ...

(GH01/ iStock) Quench Bio’s short journey has come to an end after the biotech startup found that its target was simply undruggable. The Cambridge, Massachusetts-based biotech had focused on blocking the gasdermin D protein with oral inhibitors to treat inflammatory diseases and had attempted to seek out a potent, selective chemical series to progress by the first quarter of 2021. It has not, however, managed to hit that goal, and, with credit to the company, it is not trying to spin...

EXECUTIVE CHANGES: Marlowe Poaches From Fullers; RM Promotes To CEO Fri, 26th Feb 2021 17:14 (Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday and not separately reported by Alliance News: Marlowe PLC - London-based safety and compliance services and software - Hires Adam Councell as chief financial officer. Councell is finance director of pub and hotel chain Fuller, Smith & Turner PLC. Fullers says that Councell...

Arix Bioscience PLC: Board Changes DJ Board Changes Arix Bioscience PLC (ARIX) Board Changes 25-Feb-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- Arix Bioscience plc Board Changes LONDON, 25 February 2021: Arix Bioscience plc ("Arix" or the "Company") (LS...

Investegate announcements from Arix Bioscience PLC, Notice of Results

About Arix Bioscience plc Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting-edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arix...

Top UK Stocks to Watch: Rolls Royce cuts forecasts and warns of slower recovery Joshua Warner January 26, 2021 9:42 AM Rolls Royce shares take a nosedive after lowering expectations, JD Sports considers raising equity, PZ Cussons reveals its brands remain popular during the pandemic, and UDG Healthcare targets double-digit earnings growth. Share: Top News:...

Investegate announcements from Arix Bioscience PLC, Investment team changes